Contactins (Cntns) are a six-member subgroup of the immunoglobulin cell adhesion molecule superfamily (IgCAMs) with pronounced brain expression and function. Recent genetic studies of neuropsychiatric disorders have pinpointed contactin-4 (CNTN4), contactin-5 (CNTN5) and contactin-6 (CNTN6) as candidate genes in neurodevelopmental disorders, particularly in autism spectrum disorders (ASDs), but also in intellectual disability, schizophrenia (SCZ), attention-deficit hyperactivity disorder (ADHD), bipolar disorder (BD), alcohol use disorder (AUD) and anorexia nervosa (AN). This suggests that they have important functions during neurodevelopment. This suggestion is supported by data showing that neurite outgrowth, cell survival and neural circuit formation can be affected by disruption of these genes. Here, we review the current genetic data about their involvement in neuropsychiatric disorders and explore studies on how null mutations affect mouse behavior. Finally, we highlight to role of protein-protein interactions in the potential mechanism of action of Cntn4, -5 and -6 and emphasize that complexes with other membrane proteins may play a role in neuronal developmental functions.
1. Introduction
The contactin family
The development of the central nervous system is dependent on the highly coordinated interplay of diverse cells in transition. Neural cell adhesion molecules (CAMs) are indispensable for allowing such neural cell interactions and provide support in multiple neurodevelopmental processes, including cell survival, neurite outgrowth, neuronal migration, axon guidance, and synaptogenesis (Geschwind and Levitt, 2007; Pardo and Eberhart, 2007; Rubenstein, 2011) . Recent neurobiological characterization of CAMs has revealed that complex physical interactions between different types of CAMs are involved in these cellular processes.
Contactins (Cntns) are proteins belonging to a specific subclass of the immunoglobulin CAM superfamily (IgCAM). They play critical roles in neuronal and glial networks. The Cntn family includes six members (Cntn1 to -6) that each exerts specific functions. (See contribution by Furley, A and Gennarini, G to this volume) . Although the domain organization of Cntn members is reminiscent to that of other IgCAMs (Maness and Schachner, 2007) , the structural signature of all six Cntn members consists of six N-terminal Ig domains, four fibronectin type III (FNIII) domains, and they are tethered to the cell membrane with a C-terminal glycosylphosphatidylinositol (GPI)-anchor.
Contactin-1 (Cntn1, aka F3/contactin) and contactin-2 (Cntn2, aka TAG-1) are the prototypical members of the family. They have important functions in neuron-glia interactions and formation of the nodes of Ranvier (Ascano et al., 2012; Peles and Salzer, 2000) . In addition, these two proteins regulate neuronal migration, axon guidance and the organization of myelin subdomains through cis-and trans-interactions with distinct CAMs (Mohebiany et al., 2014) . Cntn1 and Cntn2 may exemplify principal functions and mechanisms of action of the other members of this family However, the roles of contactin-3 (Cntn3 aka BIG-1), contactin-4 (Cntn4, aka BIG-2), contactin-5 (Cntn5, aka NB-2), and contactin-6 (Cntn6, aka NB-3) have been less well characterized. Interestingly, they have been put in the spotlights by recent genetic studies of neuropsychiatric developmental disorders including autism spectrum disorders (ASDs), identifying these members as candidate risk genes (Guo et al., 2012; Nava et al., 2014; van Daalen et al., 2011) . Moreover, multiple studies using null mutant mice have indicated functions of these Cntns in the developing and mature brain .
In this review, we provide an overview on the roles of Cntn4, -5 and -6 in development of neurodevelopmental disorders, the phenotypes of null mutation in mouse models and address potential molecular mechanisms by which biological functions of are brought about.
Contactin-4, -5, and -6: structural and functional relationships
The six individual members of the Cntn family share an overall 40-60% amino acid identity, but comparison of individual domains between CNTN4 and CNTN3, CNTN5 and CNTN6 demonstrated an amino acid sequence identity of roughly 70% or more for the second and third Ig domains (Zuko et al., 2011) . These two Ig domains are partly responsible for the horse shoe-shaped conformation of the Cntns at the N-terminus that also interacts with a common binding partner, namely the receptor protein tyrosine phosphatase alpha (Ptpra) (Ye et al., 2011) . The cellular function of this interaction has been suggested to relate to intracellular transport and neuritogenesis (Mercati et al., 2013; Ye et al., 2011) .
The similarities of Cntn4, Cntn5, and Cntn6 extend in part to their chromosomal localization and to their spatial and temporal expression in the developing mouse brain. CNTN4 and CNTN6 are neighboring genes in human chromosome 3 together with the related IgCAM gene close homologue of L1 (CHL1). In the mouse the syntenic locus is present on chromosome 6 and complemented with Cntn3. The temporal expression of Cntn4, -5 and -6 in mouse forebrain and cortex follow a similar profile with clear, but low expression in embryonic stages and peak expression in the first weeks after gestation (Kamei et al., 2000; Yoshihara et al., 1995; Zuko et al., 2016b) . However, the spatial expression of these genes appears to be significantly differentiated.
The expression of the Cntn4, -5 and -6 genes have been investigated over the years with different technologies and resolutions. A systematic high-resolution analysis is lacking to date. However, available studies show that all three genes are expressed in the olfactory bulb, cerebral cortex and in the thalamus, although largely in different layers and nuclei. Among these three Cntns, Cntn4 has the most extensive expression in the cortex, namely in layers II-V (Yoshihara et al., 1995) . Cntn5 is expressed in layers II-V and in the cingulum (Kleijer et al., 2015; Li et al., 2003; Ogawa et al., 2001; Toyoshima et al., 2009) , while Cntn6 expression is more confined in layers II-III and in pyramidal neurons of layer V (Lee et al., 2000; Sakurai et al., 2010; Takeda et al., 2003; Zuko et al., 2016b) . In these studies no clear distinction between expression in interneurons and pyramidal neurons could be made. From a recent high-resolution RNA-seq study a more precise link of Cntn4, -5 and -6 expression to defined neuronal types in the cerebral cortex can be made (Tasic et al., 2016) . These authors determined individual transcriptomes of differentially tagged neurons of the mouse visual cortex. We derived a semi-quantitative overview of the expression of Cntn4, -5 and -6 in cortical cell types from the data set made available through the Allen Brain Atlas (http://casestudies.brain-map. org/celltax) (Fig. 1 ). This overview shows that Cntn4 has the broadest and highest expression. The Cntn4 expression profile is characterized by expression in pyramidal neurons of layers Vb and VIa, and interneurons of virtually all types. Pyramidal neuron expression of Cntn5 is predominantly confined to layer Va, while parvalbumine-and Ndnf-positive interneurons also express Cntn5. Cntn6 is expressed by pyramidal neurons of layers Vb and VIb, specific subtypes of VIP-, SST and parvalbumine-positive interneurons. Notably, these subtypes of interneurons also expressed Cntn4 at significant levels (Fig. 1) . These expression profiles reveal that both pyramidal and interneurons express these Cntns, that expression is distinct for each Cntn, but that overlap, in particular between Cntn4 and -6, exists certain types of interneurons. These data will provide a useful scaffold for studies on the roles of Cntns in cortical development.
Notably, in the retina Cntns 1-5 are expressed differentially in distinct subsets of amacrine cells and were proposed to provide a code for lamina-specific targeting in the retina (Yamagata and Sanes, 2012) . This principle of differential Cntn expression forming a biological code may also operate in the brain, in particular in the cortex and thalamus, and may serve developmental functions.
Similarly to the cortex, Cntn4 also has the broadest expression in the thalamus, including most of the thalamic nuclei (Yoshihara et al., 1995) .
Cntn5 is most prominently expressed in the laterodorsal nucleus, but also at lower levels in the anterodorsal, anteroventral, ventrolateral nuclei and the posterior group (Kleijer et al., 2015; Li et al., 2003; Ogawa et al., 2001) . Cntn6 is only expressed in the anterodorsal, ventrolateral, medial and lateral geniculate nuclei (Sakurai et al., 2010; Takeda et al., 2003; Zuko et al., 2016b) . In contrast, all three Cntns show a similar expression in the granular layers and Purkinje cells of the cerebellum (Lee et al., 2000; Ogawa et al., 2001; Takeda et al., 2003; Yoshihara et al., 1995) .
Based on the partly differential expression pattern of these Cntns, it seems very likely that they are not redundant and that each Cntn protein plays important roles during neurodevelopment. One study compared the effects of Cntn4, Cntn5, and Cntn6 on the morphology of developing neurons in vitro (Mercati et al., 2013) , and found that overexpression of Cntn4 and Cntn6 increased the length of neurites, while Cntn5 increased the number of roots and neurite branching. The similarity of Cntn4 and Cntn6, as compared to Cntn5, has also been demonstrated in the phylogenetic analysis of the CNTN protein family (Zuko et al., 2011 (Zuko et al., , 2013 .
Genetic implication of contactin-4, -5 and -6 in neurodevelopmental disorders
Developmental neuropsychiatric disorders are a highly heterogeneous group of diseases characterized by multi-complex genetics, variable behavioral symptoms and variable pathological distributions (Zhao and Castellanos, 2016) . Copy number variations (CNVs) are structural genomic variations, either deletions or duplications, causing changes in gene dosage. Current genetic studies have shown the association of neuropsychiatric developmental disorders with CNVs in several CNTN genes (Kirov, 2015; Torres et al., 2016) . Below, we present the current evidence of the implication of CNTN4, -5 and -6 in neuropsychiatric developmental disorders and summarize these in Table 1 .
3p deletion syndrome
The 3p25 deletion syndrome, shortly 3p deletion syndrome, is a rare chromosomal abnormality characterized by deletion of the tip of the short arm of chromosome 3. It usually occurs as a de novo mutation, but sometimes it can be inherited from a parent. The symptoms include small head size (microcephaly), developmental delays, growth retardation, intellectual disability, distinctive facial features and ASDs (Dijkhuizen et al., 2006; Fernandez et al., 2004 Fernandez et al., , 2008a Fernandez et al., , 2008b Shuib et al., 2009 ). The CHL1, CNTN6 and CNTN4 genes are located in this order adjacent to each other on chromosome 3p25-p26 (Kamei et al., 1998; Wei et al., 1998; Zeng et al., 2002 ) and this locus is in the deleted region of 3p deletion syndrome. In addition, the CNTN4 gene alone can be deleted or disrupted in patients with developmental delay and features resembling the 3p deletion syndrome (Dijkhuizen et al., 2006; Fernandez et al., 2004) . Cargile et al. have also reported that loss of a single functional copy of CNTN4 contributes to the developmental delay, which is characteristic of 3p deletion syndrome (Cargile et al., 2002) .
Autism spectrum disorders (ASDs)
Autism spectrum disorders (ASDs) are a group of highly genetic, heterogeneous neurodevelopmental disorders defined by core behavior domains: impaired social interaction and communication and repetitive/restricted behavior according to DSM-5 (American Psychiatric Atlas data portal providing a graphical output of study Tasic et al., 2016 . In this study a cellular taxonomy of the primary visual cortex of adult mice was constructed on the basis of single-cell RNA sequencing. The data set included 49 transcriptomic cell types, including 23 GABAergic, 19 glutamatergic and 7 non-neuronal types obtained through transgenic Cre lines.
Association. DSM-5, 5th edition). The age of onset is before 3 years. Currently the occurrence rate of ASDs is estimated 1:68 in the United States of America and 1% in Europe, Asia and North-America. ASD is almost five times more common in boys than in girls (Developmental Disabilities Monitoring Network Surveillance Year Principal et al., 2014; Elsabbagh et al., 2012) . CNVs of CNTNs members in particular CNTN4, -5 and -6 genes have been found in patients with ASDs (Fernandez et al., 2008a; van Daalen et al., 2011) . These patients have less severe symptoms than those with the 3p deletion syndrome (Dijkhuizen et al., 2006; Fernandez et al., 2004 Fernandez et al., , 2008a Fernandez et al., , 2008b Shuib et al., 2009 ). In addition, CNVs of CNTN4 that include part of the adjacent CNTN6 gene, have been associated with ASD (Guo et al., 2012; Nava et al., 2014) . Other studies reported CNVs of CNTN4 only (Glessner et al., 2009; Roohi et al., 2009; Vardarajan et al., 2013) . Interestingly, Nava et al. reported duplications between the adjacent CNTN4 and CNTN6 genes in five unrelated ASD subjects. Intronic deletions have been identified in CNTN4 and CNTN5 (Nava et al., 2014) . Van Daalen et al. reported a CNTN5 deletion in three related ASD patients and a CNTN6 deletion and duplication in two unrelated ASD patients (van Daalen et al., 2011) . In the meantime, four different variants of CNTN4 have been identified in unrelated cases with ASDs (Cottrell et al., 2011) . However, Murdoch et al. have performed next-generation sequencing in cohorts totaling 2704 sporadic ASD cases and 2747 controls and reported the lack of statistical evidence for significant association of rare heterozygous mutations in any gene of the CNTN family (Murdoch et al., 2015) . Similarly, Zuko et al. (2016a) have identified variants in CNTN4, -5, and -6 genes in multiplex families Poot (2014 with ASD. Based on cosegregation analysis in pedigrees no evidence was obtained that single nucleotide variants in these CNTN genes contributed to ASD development. However, Liu et al. suggested significant associations between ASD and CNTN4 in East Asian populations . Mercati et al. also reported deleterious variants in CNTN5 and CNTN6 including multiple copies of CNTN5, and a number of coding variants in CNTN6, in ASD patients (Mercati et al., 2016) . The current data indicate that particularly CNVs in CNTN4, -5 and -6 may relate to the occurrence of ASDs, and that many single nucleotide variants are less penetrant, or represent polymorphisms. For several of these a causative relation to ASD may exist. Clearly, further investigation is necessary to clarify the genetic involvement of CNTNs genes with ASDs.
Anorexia nervosa (AN)
Anorexia nervosa (AN) is an eating disorder with the highest mortality of all psychiatric disorders (Arcelus et al., 2011) . Patients lose weight even when they are underweight and have an intense fear of gaining weight (Attia, 2010) . People with AN, most commonly adolescentonset female individuals, clinically display food restriction, weight loss and body image distortions (Smink et al., 2012) . AN is a complex disorder and the biological causes of AN are still unknown. Currently, it is thought that AN develops as a result of multiple factors, including genetics, hormonal state and also social attitudes (Herpertz-Dahlmann et al., 2011) .
CNTN genes have emerged in genetic studies focusing on AN. In genome-wide analysis of CNVs disruptions of the CNTN6/CNTN4 region were found in several AN cases (Wang et al., 2011) . For CNTN5 it has been reported that a linkage disequilibrium block including exon 9 of the CNTN5 gene was one of the two loci that significantly associated with AN in a group of 340 AN patients (Nakabayashi et al., 2009) . These data suggest that variants in CNTN4, -5 and -6 may also be involved in other neuropsychiatric disorders like AN, and suggest that these CNTNs play a role in the physiological systems underlying the pathogenesis of AN.
Schizophrenia (SCZ)
Schizophrenia (SCZ) is a chronic, severe and clinically heterogeneous mental disorder that is associated with positive and negative symptoms including disruption of thinking, managing emotions and making decisions. SCZ is a complex illness with lifelong morbidity affecting about 1% of the population. The average age of onset is between 16 and 30 years old (van Os and Kapur, 2009) . SCZ is considered to have a neurodevelopmental origin and has been subject to intense genetic analyses showing that like ASD, the genetics of SCZ is complex and heterogeneous. CNTN genes have not emerged in prominent loci in genome-wide association studies (GWAS). However, there are several reports that point to CNTN4 and CNTN6 as candidate risk genes in SCZ (Okbay et al., 2016) .
Zhao et al. performed a SNP association study of 167 candidate genes for SCZ. In the CNTN4 and CNTN6 genes 381 and 146 SNPs were examined, respectively. In both genes at least one significant SNP was found, however none of the SNPs were significant after gene-or experiment-wide correction for multiple testing. In a further meta-analysis by using three additional GWAS datasets, the SNP found in CNTN4 reached nominal significance (Zhao et al., 2013) . Furthermore, Goes et al. studied 592 cases with SCZ and 505 controls of Ashkenazi Jewish (AJ) ancestry by GWAS ascertained in the United States of America. In this study, meta-analysis with an Israeli AJ sample of 913 cases and 1640 controls, showed that CNTN4 was a significant candidate gene Goes et al. (2015) . Currently the largest sequencing study also showed that CNTN4 is in a schizophrenia locus, suggesting that variants may contribute to altered gene expression and liability (Fromer et al., 2016 ).
Bipolar disorder (BD)
Bipolar disorder (BD) is one of the major mental illnesses characterized by unusual shifts between depression and elevated mood (hypomania) (Anderson et al., 2012) .
Approximately, 2.6% of adults are affected in the United States of America, with the risk of suicide whilst suffering from BD is N6% (Schmitt et al., 2014) . The cause may relate both to genetic and environmental factors. Recent studies suggest that a history of childhood abuse (Carta and Angst, 2016) and strong or long-term stress may become one of the triggers of this disorder (Hosang et al., 2012) . Like ASDs and SCZ, BD is considered to be a neurodevelopmental disorder (Waltereit et al., 2014) . A hint to the involvement of CNTN4 and/or CNTN6 has been provided by studying the association of SNPs with patient subgroups defined by co-morbidity in the Caucasian GAIN BD sample of 1000 cases and 1034 controls. In this study, BD with alcohol dependence, but not BD without co-morbidities, was associated with SNP rs2727943 on chromosome 3p26.3 located between the genes CNTN4 and CNTN6 (Kerner et al., 2011 ).
Attention-deficit hyperactivity disorder (ADHD)
Attention-deficit hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders in childhood. Patients with ADHD are unable to pay attention, stay focused and control their behavior. In addition, they show impulsive hyperactive behavior (Sroubek et al., 2013) . The onset of ADHD is usually around the time the child enters preschool and persists in the early school years. 9% of American children are affected by ADHD (The Diagnostic and Statistical Manual for Mental Disorders, Fourth Edition). CNTN4 directly affected by CNVs was overrepresented in individuals with ADHD (Elia et al., 2012; Lo-Castro and Curatolo, 2014) . Lionel et al. also identified CNTN5 among de novo and rare inherited CNVs in 248 unrelated ADHD patients (Lionel et al., 2011) . In another study, a female subject with ASD and ADHD was carrying five copies of CNTN5 (Mercati et al., 2016) . Hu et al. identified the deletion of the CNTN6 gene in 14 ADHD patients, of which two patients carried a CNV encompassing the CNTN6 gene alone. The CNV in one patient consisted of a deletion of the full CNTN6-CNTN4-CHL1 locus (Hu et al., 2015) .
Alcohol use disorder (AUD)
Alcohol use disorder (AUD) is generally known as alcoholism and alcohol abuse. Currently, approximately 7.2% of adults in the United States of America have AUD. Clark et al. performed a methylome-wide association study (MWAS) combined with GWAS data to address genetic correlates for alcohol use for 619 individuals. The most significant region was found to be located in an intron of CNTN4, between SNPs rs1382874 and rs1382875. In replication, the CNTN4 gene appeared the most significant risk factor for regular alcohol use (Clark et al., 2015) .
These findings provide genetic evidence to support that deletions or duplications of the CNTNs genes are associated with neurodevelopmental disorders affecting behavior (Table 1 ). The common theme for CNTN4, -5 and -6 is that their variants are detected only in rare cases or with low significance. In most cases these variants are CNVs. A notable aspect is the emergence of deletions of CNTN4 in combination with CNTN6 in multiple disorders. This may be explained by an involvement of CNTN4 in common endophenotypes underlying all these disorders, or by a general "neurodevelopmental vulnerability" caused by altered gene dosage in CNV carriers.
As noted, in all disorders variants in CNTN4, -5 or -6 are extremely rare. However, understanding their mode of cellular action and defining the phenotypes generated by their loss of function may help to elucidate pathogenesis in cell and animal models. To provide understanding of these aspects we will focus on the phenotypes in brain and behavior of null mutant mice and discuss their mode of action. Finally, it is important to note that genetic association of CNTN4, -5 and -6 has also been found for non-neurological disorders, in particular in cancer and cardiovascular conditions. CNTN4, and -6 have both been associated with ovarian cancer, while by itself CNTN4 is associated with gallbladder cancer (Cha et al., 2012) . In addition, CNTN4 is associated with altered blood pressure (Cha et al., 2012) , CNTN6 with venous thromboembolism (Tang et al., 2013) and CNTN5 with atrial fibrillation (Larson et al., 2007) . It is not been explored if variant carriers in these studies have psychiatric or neurological problems.
Behavioral phenotypes of Cntn4, -5 and -6 null mutants
In view of the face validity of the behavioral symptoms of neuropsychiatric disorders and to understand the functional consequences of mutation of neuropsychiatric candidate genes, it is necessary to employ behavioral tasks in animal models. A conceptual issue on mouse models mimicking human genetic abnormalities concerns the mouse genotypes created for analysis. Since human neuropsychiatric disorders and these can transpire differently in animals, especially, in humans the genetic defects can be only partly penetrant, confined to one allele, or genetically subtle, like a single SNP. We thus need to concern that the subtlety of phenotypes observed in these mice rule out the consequences of these mutations found in humans because we sometime cannot detect the behavioral robust in mice models, however it may also be very different between spices. Although there are no perfect behavior models and it is difficult to directly compare the behavior between mice and Human, these mice behavior tasks still reveal us some key behaviors for these issues. Here, we review the behavioral characteristics of mouse models of Cntn4, -5 and -6 (Table. 2), these mouse models have been developed by null mutation of the gene of interest (Kaneko-Goto et al., 2008; Li et al., 2003; Takeda et al., 2003) , and compare these with clinical symptoms of associated neuropsychiatric disorders, especially ASD.
Cntn4
As describe above CNTN4 is one of the strong candidate risk genes for neuropsychiatric disorders, including ASDs. Molenhuis et al. (2016) initially screened behavioral phenotypes in Cntn4 knockout mice by assessing neurological and cognitive behaviors during different developmental stages of mice. However, no effects of Cntn4 deficiency on ASD-related behavioral mouse paradigms were observed, including the juvenile social interaction test, the three-chamber test, grooming behavior, and sensorimotor coordination (Molenhuis et al., 2016) . Also, in an extended SHIRPA screen, no significant changes were observed.
One of the autism-related behaviors is lack of cognitive flexibility. Since it was hypothesized that Cntn4 -/-mice may show the abnormality of the flexibility, these mice were subjected to the set-shifting task and Barnes maze reversal-learning paradigm. However, both results suggested that Cntn4 disruption had no effect on cognitive flexibility. Interestingly, while there was no difference in the Barnes maze reversallearning paradigm, Cntn4 -/-mice revealed faster escape hole finding during subsequent days of acquisition in the Barnes maze paradigm. They also found an increased startle response to auditory stimuli of different high amplitudes. In this test battery Cntn4 -/-mice revealed a hyper-response to acoustic stimuli. This hyper-reactivity was not related to anxiety, because Cntn4 -/-mice were not altered for their behavior in the elevated plus maze and open field test (Blanchard et al., 2003) . Interestingly, hyper-reactivity to acoustic stimuli has been reported for several neuropsychiatric disorders (Sauer et al., 2014; Silverman et al., 2010; Weidt et al., 2016) including ASDs (Green et al., 2015; Takahashi et al., 2014) . These data indicate that disruption of Cntn4 does not affect specific autism-related phenotypes but causes subtle non-disorder specific changes in sensory behavioral responses and cognitive performance (Table 2 ). In the studies of Molenhuis et al. an olfactory functional test based on buried food revealed no olfactory dysfunction in Cntn4 -/-mice (Molenhuis et al., 2016) . This is of interest in view of the reported effects of Cntn4 on specific arborization of olfactory sensory neurons (Kaneko-Goto et al., 2008) and retinal ganglion cell axons (Osterhout et al., 2015) . Kaneko-Goto et al. showed that Cntn4 acts as an axon guidance molecule and is required for correct neuronal wiring in the mouse olfactory system. Additional olfactory tests may be necessary to probe the olfactory system for Cntn4-dependent functions further. In the visual system, Osterhout et al. investigated potential defects in the innervation of the nucleus of the optic tract (NOT) in Cntn4 -/-mice. Dark-adapted head-fixed mice with horizontal or vertical stimuli optimal for eye movements were investigated and c-Fos immunoreactivity was determined (Osterhout et al., 2015) . The results revealed that Cntn4 -/-mice have a significantly reduced number of c-Fos + cells upon a horizontal motion stimulus. To address whether the accessory optic system (AOS) regulates the input to the NOT and contributes to the behavior, optokinetic reflex behavior were measured ( Table 2) . The results suggested that loss of Cntn4 alters AOS-driven behaviors for image stabilization. These data indicated that loss of Cntn4 caused changes in the afferents from the retinofugal pathway, resulting in this sensory defect.
Cntn5
Sensory defects have also been observed in Cntn5 -/-mice using a paradigm in which exposure to acoustic stimuli causes audiogenic seizures (AGS). Cntn5 -/-mice were less susceptible to AGS compared to control mice, which was reflected by a significantly lower c-Fos expression in the dorsal and external cortex of the inferior colliculus (IC) (Li et al., 2003) . The Cntn5 -/-mice were not hearing-impaired, but the auditory brainstem response wave latency appeared delayed (Table 2 ). The authors suggested a general reduction in brain activity upon stimulation. Next, the response to a pure tone stimulus was examined by c-Fos expression in the central nucleus of the inferior colliculus (CIC). During development, axon collaterals are initially broadly distributed in the IC, but through elimination an experienceand activity-dependent organization is formed, which results in frequency-selective bands in adult animals (Pierson and Snyder-Keller, 1994 ). This organization serves as functional marker of pre-to postsynaptic information transfer in the auditory pathway (Chen et al., 2000) . An important finding is the sensory expression of a Cntn5-Cntnap4 co-receptor complex directing the high-density accumulation of GABAergic boutons on sensory terminals (Ashrafi et al., 2014) . It is of interest to note that ASD patients with mutations in the CNTN5 gene displayed hypersensitivity to sounds (hyperacusis) and changes in wave latency within the auditory pathway (Mercati et al., 2016) . We have begun to study ASD-related behaviors in Cntn5 -/-mice (Kleijer et al., unpublished) . As yet, these studies showed that there are no gross changes in social and spontaneous behaviors in the mutant mice compared to wild-type littermates. Therefore, it seems that behavioral phenotypes may be subtle and confined to specific challenges including sensory stimuli.
Cntn6
Similarly to CNTN5, ASD patients with variations in the CNTN6 gene were hypersensitive to acoustic stimuli (Mercati et al., 2016) . However, sensory responses have not been addressed directly in Cntn6 deficient mice. Rather, motor coordination and muscle strength have been studied in these mice, in view of the high Cntn6 expression in the cerebellum . This study has revealed that Cntn6 -/-mice are inferior to wild-type mice in staying and walking on a rotating rod during repeated trials (Table 2 ). To understand whether this was due to a decrease in muscle strength, the mice were subjected to the wire-hang and the horizontal rod-walking tests. However, Cntn6 -/-mice did not perform any different compared to wild-type control mice in these tests, suggesting that Cntn6 deficiency leads to defects in motor coordination, rather than muscle strength, which is a cerebellum related defect. So far, studies on ASD-related behaviors in Cntn6 -/-mice, such as social interaction, social communication, and repetitive and restricted behaviors, are still lacking. As yet, we can only speculate on the social behavior of Cntn6 deficient mice based on the observed shift in the numbers of subtype-specific projection neurons and interneurons in the visual cortex of Cntn6 deficient animals (Zuko et al., 2016b) . This shift might disrupt the excitation/inhibition balance in the cortex, which can lead to deficits in social behavior and information processing (Yizhar et al., 2011) as is the case in Contactin-associated protein-2-(Cntnap2)-deficient mice, which display a highly asynchronous cortical neuronal activity (Peñagarikano et al., 2011) . Abnormal neuronal synchrony is an ASD phenotype (Sohal et al., 2009; Uhlhaas and Singer, 2006) , and concurrently, mutations in Cntnap2 have been associated with this disorder (Alarcón et al., 2008; Egger et al., 2014; Nord et al., 2011; Rossi et al., 2008) . Cntnap2 -/-mice displayed further ASD-related behavioral phenotypes including repetitive behavior, impaired communication and social behavior (Peñagarikano et al., 2015) . Therefore, the comparable but subtle neuroanatomical phenotype in Cntn6 deficient mice might suggest that more subtle similar behavior abnormalities may exist in Cntn6 -/-mice as well.
Molecular mechanisms of action of contactin-4, -5 and -6
Cellular functions of Cntn4, -5, and -6 related to neurodevelopment have emerged from studies in mice deficient for these Cntn genes. Although the gross neuroanatomy was not affected (Kaneko-Goto et al., 2008; Li et al., 2003; Takeda et al., 2003) , more detailed analyses in specific processes in neurodevelopment did demonstrate impairments in several neurobiological processes, including axonal guidance and outgrowth, the orientation of elongating dendrites, and synaptogenesis (Huang et al., 2012; Kaneko-Goto et al., 2008; Osterhout et al., 2015; Toyoshima et al., 2009; Yamagata and Sanes, 2012; Ye et al., 2008) . However, the molecular mechanisms underlying these functions of Cntn4, Cntn5 and Cntn6 have largely remained unclear. Since Cntns lack transmembrane-and intracellular domains, they cannot activate intracellular signal transduction on their own, but need cis-interacting partners to confer a signal. Moreover, contactins can act as ligands to receptors on other cells. Therefore, there functioning is closely dependent on interaction in cis or trans with membrane-spanning proteins.
Cntn1 (contactin) and Cntn2 (TAG-1) are pivotal examples for the molecular mechanisms by which contactins mediate cellular functions. Their roles in the architecture of the node of Ranvier in myelinated nerves have demonstrated the importance of the formation of complex protein networks in the intercellular space (Peles et al., 1995; Peles and Salzer, 2000; Poliak and Peles, 2003) . For example, it has been shown that Cntn2 forms a homophilic trans-interacting spanning the axolemma and the glial membrane, and simultaneously binds to Cntnap2 in cis on the axolemma. In turn, the intracellular domain of Cntnap2 binds to the signal transduction protein 4.1B in the axoplasm Table 3 Proteins with stabilized interactions with Cntn4, Cntn5, and Cntn6.
Contactin protein
Interactor Specifics Cntn4 APP (Osterfield et al., 2008; Osterhout et al., 2015) Amyloid precursor protein APPsα (Osterfield et al., 2008) Cleaved ectodomain of APP APLP1 (Osterfield et al., 2008) Amyloid precursor-like protein 1 Ptprg (Bouyain and Watkins, 2010) Protein tyrosine phosphatase gamma Cntn5 APLP1 (Osterfield et al., 2008 Amyloid precursor-like protein 1 Ptprg (Bouyain and Watkins, 2010) Protein tyrosine phosphatase gamma Cntnap4 (Ashrafi et al., 2014) Contactin associated protein 4 Cntn6
Chl1 (Ye et al., 2008) Close homologue of L1 Ptpra (Ye et al., 2008) Protein tyrosine phosphatase alpha Notch (Cui et al., 2004; Hu et al., 2006) Triggers translocation of NICD Ptprg (Bouyain and Watkins, 2010) Protein tyrosine phosphatase gamma Ptprs (Huang et al., 2016) Protein tyrosine phosphatase sigma and clusters potassium channels Horresh et al., 2010) . This complex illustrates the functional capacity of Cntns to form cis-as well as trans-networks involving homophilic and heterophilic interactions. Consequently, in following years, findings have accumulated that such types of protein-protein interactions also exist for Cntn4, -5 and -6. Presently known interactions are summarized in Table 3 . These studies have been discussed extensively in a previous review (Zuko et al., 2011) . Recently, several new observations have been made that contribute to understanding the significance and biological functions of these interactions on which we focus below.
Cntn4
Bouyain and Watkins et al. demonstrated a crystal structure study between CNTN4 (four N-terminal Ig repeats) and PTPRG (CA-like domain) and it has given us the structural insights for the interaction (Bouyain and Watkins, 2010) . This finding suggests that the N-terminal region of CNTN4 adopts a horseshoe-like conformation and implicates PTPRG, PTPRZ and CNTNs as a group of receptors and ligands in the developmental nervous system (Table 3) .
A recent study has revealed another biological function for the Cntn4-APP (Amyloid precursor protein) complex in vitro (Osterfield et al., 2008) and in vivo (Osterhout et al., 2015) (Table 3 ). Additionally, Cntn4 was found to interact with amyloid precursor-like protein 1 (APLP1) (Osterfield et al., 2008) . It has been shown that Cntn4 can bind to APP and that the binding affects neurite outgrowth in cultured neurons (Osterfield et al., 2008) . Osterhout et al. showed that APP is required for Cntn4-mediated axonal arborization in retinal ganglion cells (RGCs) (Osterhout et al., 2015) . It was demonstrated that APP is coexpressed with Cntn4 on axons of retinal ganglion cells (RGC). Both proteins were required for RGC axon targeting onto the NOT, in which APP most likely acts as co-receptor with Cntn4 allowing Cntn4 to impart its role in target specificity (Glessner et al., 2009; Osterhout et al., 2015) . These data show that the mechanism of action of Cntn4 involves a cisinteraction between this contactin and another membrane-associated protein. This theme bears similarities to the well-established Cntn2-Cntnap2 interaction in the node of Ranviers. Furthermore, a recent study in zebra fish suggests that CNTN4 overexpression causes a significant decrease in head size and proliferating cells marked by phosphohistone3 (PH3), affecting neurodevelopment (Fromer et al., 2016) . These neurodevelopmental changes may involve Cntn4 interactions with other proteins and functions of protein complexes.
Cntn5
Support for involvement of Cntn5 in the process of arborization comes from an in vitro study by Mercati et al. (2013) . Cntn5 overexpression resulted in an increase in the number of roots and promoted progressively neurite branching. It was also found to promote neurite elongation of rat cortical neurons in culture (Ogawa et al., 2001) . In addition to Cntn4, APLP1 was found to interact with Cntn5 (Osterfield et al., 2008; Shimoda and Watanabe, 2009) . In in vitro studies it has been shown that Cntn5 and APLP1 can form a cis-complex at the site of the presynapse. Further investigation revealed that Cntn5 and APLP1 have partially overlapping spatiotemporal expression patterns, which supports the possibility of interaction in vivo. The authors speculated that a cis-interaction between Cntn5 and APLP1 prevents APLP1 to form homodimers, which are implicates in synaptogenesis (Osterfield et al., 2008; Shimoda et al., 2012) .
This theme also applies to the mode of action of Cntn5 as recently demonstrated in one particular neural circuit (Ashrafi et al., 2014) . Cntn5 is expressed on proprioceptive sensory neurons in the spinal cord and interacts presynaptically in cis with Cntnap4 (Ashrafi et al., 2014) . Absence of Cntnap4 prevents high bouton-packing on sensory proprioceptive neurons, as was observed in Cntn5-deficient mice. This phenotype was also present in mice deficient for both Cntn5 and Cntnap4 (Ashrafi et al., 2014) , supporting the view that Cntn5 and Cntnap4 act as coreceptors on sensory terminals to direct the formation of GABApre bouton synapses. To identify the ligands of this complex, CAMs on GABApre neurons were investigated. NrCAM and Chl1 were identified on GABApre interneurons and absence of these proteins resulted in a decrease of GABApre bouton density on sensory terminals, indicating a role for these two CAMs in the organization of GABApre synapses. Mice deficient in both NrCAM and Cntn5 showed a strong reduction in the number of GABApre boutons that form on sensory (Ashrafi et al., 2014) , which supports the idea that GABApre-derived NrCAM and sensory-derived Cntn5 might form a ligand-receptor pair that directs high-density GABApre bouton formation with sensory afferent terminals (Ashrafi et al., 2014) . The model that arises from this study is a heteromeric cis-complex between Cntn5 and Cntnap4 on the sensory terminal that interacts with NrCAM and Chl1. Whether the latter two proteins form a physical complex was not determined. Furthermore, a recent study suggests that Cntnap4-deficiency has an effect on DA and GABA signaling (Karayannis et al., 2014) . If expression of Cntn5 is absent, Cntnap4 may not have optimally functions and the signaling may be affected. Such mechanism may also underlie biological effects of Cntn5 in other systems like in the hypothesized function of Cntn5 in glutamatergic synapse formation, maturation and stabilization.
Cntn6
The pivotal example that Cntn6 can also be engaged in functional cisinteractions is the study by Ye et al. on cortical morphology in Cntn6 -/-mice (Ye et al., 2008) . These authors showed that the absence of Cntn6 resulted in altered apical dendritic orientation of visual cortical pyramidal neurons. This phenotype was mild in Cntn6 +/-and Chl1 +/-mice, but enhanced in Cntn6 +/-::Chl1 +/-mice. Due to the presence of both these genes in the same locus, double null mutants could not be created and studied. They further proposed a role for protein tyrosine phosphatase α (PTPα). The interaction between Cntn6 and Chl1 was further elaborated in an elegant recent study on the regrowth of the corticospinal tract into the scar after spinal cord injury (Huang et al., 2016) . In this model, expression of Cntn6 and Chl1 was induced by spinal cord transection forming a cis-complex on the corticospinal axons and the scar-forming cells. These heteromeric complexes appeared to bind each other in trans and could lead to signaling in the corticospinal axons through PTPσ. It was proposed that the Cntn6 molecules mediated the binding of these complexes in a homophilic fashion. In this spinal cord injury model Cntn6 deficiency promoted the functional capacity of regenerating axons. Notably, the same authors also reported earlier that Cntn6 deficiency delays the development of the corticospinal tract under normal conditions (Huang et al., 2016) . Cntn6 interacts to Chl1 and Ptpra to maintain the correct angle of apical dendrite orientation of pyramidal neurons in the neocortex. In this complex, Ptpra most likely acts downstream of Cntn6 and Chl1. Ptpra mediates signaling to the intracellular tyrosine kinase p59fyn. The kinase activity of p59fyn is inhibited through intramolecular interaction between physphorylated Tyr-531 and its SH2 domain, which stabilizes a noncatalytic conformation. Ptpra activates p59fyn via dephosphorylation of the Tyr-531 site.
P59fyn is important for cell growth and survival, cell adhesion, cytoskeletal remodeling, cell motility and axon guidance. Impairment of this cascade, therefore, leads to aberrant apical dendrite orientation of pyramidal neurons in the neocortex, which may partly explain the underlying mechanism of the development of 3p deletion syndrome. These seemingly contrasting observations have remained unexplained however. It remains to be determined if the Cntn6-Chl1 complex is involved in normal development as in the response to injury. Recent proteomics studies on Cntn6 have strengthened the theme of functional cis-interactions (Zuko et al., 2016a) . Firstly, these studies showed that the identified proteome for Cntn6 was different from that of Cntn5 (b 10% overlap), and that the proteome of Cntn6 overlapped for about 50% with that of Cntn4; 40% of the Cntn5 proteome overlapped with Cntn4. Moreover, the data revealed one other membrane protein that formed a functional cis-complex with Cntn6. This complex engaged Cntn6 in inhibition of apoptosis. Moreover, it explained phenotypes of increased apoptosis in the cerebellum and cortex of Cntn6 -/-mice Zuko et al., 2016a) .
Conclusion
Contactins 3-6 have long been the obscure members of the Cntn family. Due to genetic and neurobiological studies the latter three received more light recently. We can now conclude that Cntn4, -5 and -6 regulate developmental processes which, when affected by loss-offunction of either of these CNTNs in man, can lead to neuropsychiatric developmental disorders. The clinical phenotypes appear to be very divers, ranging from mental retardation to ASD and anorexia nervosa. This may indicate that they affect general underlying developmental processes in a non-specific way, or need other factors to induce symptoms and phenotypes. The results of behavioral studies in mouse null mutants showing at best mild phenotypes may support the possibility that the effect of mutations in humans are enhanced by concomitant mutation in other genes or by genetic background. For further understanding of their contributions to neuropsychiatric developmental disorders we need more insight into their molecular mechanisms of action. One of these modes engages other membrane proteins in cis-interactions and results in functional complexes. Cntns may act in these complexes as co-receptors, modulators or ligands. At this moment it demonstrates that other proteins are needed for Cntns to expose their full biological potential. This potential is apparently essential for normal brain development. A further experimental direction is the creation of simultaneous mutations in one of the Cntns and genes coding for interaction proteins. Furthermore, understanding the implication of the interacting proteins for the behavioral trait in mouse models and ultimately for the psychiatric disorder is current point of focus of research.
